These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7099105)

  • 1. [Diagnosis of occult skeletal metastasis: alkaline phosphatase versus skeletal scintigraphy].
    Zieger M
    Med Klin Prax; 1982 May; 77(11):44-50. PubMed ID: 7099105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of preoperative bone and liver scans and alkaline phosphatase in the evaluation of breast cancer patients.
    Brar HS; Sisley JF; Johnson RH
    Am J Surg; 1993 Feb; 165(2):221-3; discussion 224. PubMed ID: 8427400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone and total alkaline phosphatase for screening skeletal metastasis in patients with solid tumours.
    Schindler F; Lajolo PP; Pinczowski H; Fonseca FL; Barbieri A; Massonetto LH; Katto FT; Del Giglio A
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):152-6. PubMed ID: 18302652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone scanning and plasma phosphatases in carcinoma of the prostate.
    O'Donoghue EP; Constable AR; Sherwood T; Stevenson JJ; Chisholm GD
    Br J Urol; 1978 May; 50(3):172-7. PubMed ID: 753455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal scintigraphy. The use of technetium 99M-labeled complexes in the detection of early osseous involvement by metastatic tumors.
    Hopkins GB; Kristensen KA; Campbell CG
    West J Med; 1974 Jun; 120(6):448-51. PubMed ID: 4845922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is routine bone scanning justified during the after-care for breast cancer?].
    Schuster R; Lenzhofer R; Pirich K; Dudzak R; Gabl F
    Dtsch Med Wochenschr; 1984 Oct; 109(43):1639-42. PubMed ID: 6149114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma acid and alkaline phosphatase in patients with breast cancer.
    Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A
    Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [X-ray and scintigraphic diagnosis of skeletal diseases compared with alkaline phosphatase activity].
    Bessler W
    Schweiz Med Wochenschr; 1974 Mar; 104(10):333-40. PubMed ID: 4818629
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitivity of 18 F bone scans in the search for metastases.
    Sharma SM; Quinn JL
    Surg Gynecol Obstet; 1972 Oct; 135(4):536-40. PubMed ID: 5085991
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate.
    Schaffer DL; Pendergrass HP
    Radiology; 1976 Nov; 121(2):431-4. PubMed ID: 981622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum alkaline phosphatase determination in patients with positive bone scans.
    Cowan RJ; Young KA
    Cancer; 1973 Oct; 32(4):887-9. PubMed ID: 4751918
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of bone and liver scans in surveying patients with breast cancer for metastatic disease.
    Evans DM; Wright DJ
    Am Surg; 1987 Oct; 53(10):603-5. PubMed ID: 2823653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of urinary hydroxyproline and bone isoenzyme of alkaline phosphatase in the early detection and follow-up of bone metastasis in breast cancer patients.
    Frenay M; Namer M; Boublil JL; Khater R; Viot M; François E; Milano G
    Bull Cancer; 1988; 75(6):533-9. PubMed ID: 3416085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [General activity and isoenzymatic spectrum of alkaline phosphatase in the diagnosis of breast cancer metastases].
    Pashintseva LP; Portnoĭ SM
    Vestn Khir Im I I Grek; 1981 Jan; 126(1):62-6. PubMed ID: 7222422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reevaluation of bone scans in breast cancer.
    Hayward RB; Frazier TG
    J Surg Oncol; 1985 Feb; 28(2):111-3. PubMed ID: 3918216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow-up of patients with breast cancer.
    Reale MG; Santini D; Marchei GG; Manna A; Del Nero A; Bianco V; Marchei P; Frati L
    Int J Biol Markers; 1995; 10(1):42-6. PubMed ID: 7629426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of serum alkaline phosphatase bone isoenzyme in prostatic carcinoma with bony metastasis.
    Chen SS; Chen KK; Lin AT; Chang YH; Wu HH; Hsu TH; Chang LS
    Br J Urol; 1997 Feb; 79(2):217-20. PubMed ID: 9052473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate.
    Merrick MV; Ding CL; Chisholm GD; Elton RA
    Br J Urol; 1985 Dec; 57(6):715-20. PubMed ID: 4084732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
    Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
    Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
    Ritzke C; Stieber P; Untch M; Nagel D; Eiermann W; Fateh-Moghadam A
    Anticancer Res; 1998; 18(2B):1243-9. PubMed ID: 9615795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.